Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal
Drug and Alcohol Dependence
Date
2024-06-30
Source
OpenAlex
DOI
10.1016/j.drugalcdep.2023.110575
PubMed
Unavailable

Authors

Denise C. VidotBria-Necole DiggsAmrit BaralMichaela E. LarsonSitara M. WeerakoonMoudou BaquaiRamessu IyiMichelle WeinerMarlene Camacho-RiveraSarah Messiah
Watch author

Topics and keywords

psilocybin AddictionSpirituality Other Coronavirus disease 2019 (COVID-19)CannabisPandemicPsilocybin2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Marijuana smokingMedicineEffects of cannabisVirologyPsychiatryHallucinogenSubstance abuseInfectious disease (medical specialty)Internal medicineOutbreakCannabidiolDiseasePolysubstance dependenceCannabis and Cannabinoid Research

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study2024-06-30

Related papers

Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-04-30Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-27The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-28Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-06-12Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08